Hoshi K, Kunikata H, Aizawa N, Yasuda M, et al. Baseline characteristics associated with the incidence of intraocular inflammation after the intravitreous injection of brolucizumab. Int Ophthalmol 2023 Dec 3. doi: 10.1007/s10792-023-02870.
PMID: 38044420